FDA — authorised 14 January 2013
- Application: NDA203634
- Marketing authorisation holder: SALIX
- Local brand name: UCERIS
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 Ekmasonid in United States
FDA authorised Ekmasonid on 14 January 2013
Marketing authorisations
FDA — authorised 7 October 2014
- Application: NDA205613
- Marketing authorisation holder: SALIX
- Local brand name: UCERIS
- Indication: AEROSOL, FOAM — RECTAL
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Ekmasonid approved in United States?
Yes. FDA authorised it on 14 January 2013; FDA authorised it on 7 October 2014.
Who is the marketing authorisation holder for Ekmasonid in United States?
SALIX holds the US marketing authorisation.